About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
2017 – Zydus launched India’s first Tetravalent Inactivated Influenza vaccine – VaxiFlu – 4
Post navigation
Previous:
2017 – Zydus Cadila acquired Sentynl Therapeutics Inc., US-based specialty company
Next:
2017 – Zydus received regulatory approval of LipaglynTM in Mexico